Diversified Healthcare Trust (DHC) Financials

$3.48 +0.04 (+1.16%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$3.48 0.00 (-0.14%)

As of 08:02 AM Eastern

Annual Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-16	-294	-370
Consolidated Net Income / (Loss)	-16	-294	-370
Net Income / (Loss) Continuing Operations	-16	-294	-370
Total Pre-Tax Income	-21	-273	-371
Total Operating Income	-94	-103	-126
Total Gross Profit	1,284	1,410	1,495
Total Revenue	1,284	1,410	1,495
Operating Revenue	1,284	1,410	1,495
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	1,377	1,514	1,621
Selling, General & Admin Expense	1,136	1,200	1,263
Depreciation Expense	239	284	285
Impairment Charge	0.00	18	71
Restructuring Charge	2.61	11	2.51
Total Other Income / (Expense), net	73	-169	-246
Interest Expense	239	194	236
Interest & Investment Income	16	24	8.95
Other Income / (Expense), net	296	1.21	-19
Income Tax Expense	0.71	0.45	0.47
Other Gains / (Losses), net	6.06	-20	1.60
Basic Earnings per Share	($0.07)	($1.23)	($1.55)
Weighted Average Basic Shares Outstanding	238.31M	238.84M	239.54M
Diluted Earnings per Share	($0.07)	($1.23)	($1.55)
Weighted Average Diluted Shares Outstanding	238.31M	238.84M	239.54M
Weighted Average Basic & Diluted Shares Outstanding	239.68M	240.42M	241.27M
Cash Dividends to Common per Share	$0.04	$0.04	$0.04

This table shows Diversified Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-81	-65	-53	-73	-66	-103	-86	-98	-99	-87	-8.99
Consolidated Net Income / (Loss)	-81	-65	-53	-73	-66	-103	-86	-98	-99	-87	-8.99
Net Income / (Loss) Continuing Operations	-81	-65	-53	-73	-66	-103	-86	-98	-99	-87	-8.99
Total Pre-Tax Income	-84	-63	-52	-75	-65	-80	-88	-85	-99	-99	-10
Total Operating Income	-33	-18	-17	-33	-21	-33	-27	-16	-42	-41	-36
Total Gross Profit	323	337	346	346	357	362	371	371	374	380	387
Total Revenue	323	337	346	346	357	362	371	371	374	380	387
Operating Revenue	323	337	346	346	357	362	371	371	374	380	387
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	356	355	363	379	377	394	398	387	416	421	423
Selling, General & Admin Expense	295	291	292	294	305	309	315	310	324	314	323
Depreciation Expense	60	63	65	68	67	84	70	68	69	78	68
Impairment Charge	0.00	-	5.93	11	1.16	-	12	6.55	23	29	38
Restructuring Charge	0.29	0.78	0.09	6.04	3.68	1.04	0.09	1.83	0.33	0.27	0.02
Other Special Charges / (Income)	-	-	-	-	-	-	-	-	-	-	-7.52
Total Other Income / (Expense), net	-51	-45	-35	-42	-45	-47	-61	-70	-57	-58	25
Interest Expense	47	49	49	47	48	50	58	59	59	60	87
Interest & Investment Income	1.43	22	12	5.13	3.24	2.96	2.24	2.40	2.58	1.74	2.10
Other Income / (Expense), net	-5.04	-17	1.23	0.00	0.00	-0.03	-5.87	-13	0.11	0.04	110
Income Tax Expense	0.01	-0.14	-0.03	0.22	0.19	0.07	0.19	0.17	0.15	-0.04	0.05
Other Gains / (Losses), net	2.13	-2.63	-0.65	2.93	-0.15	-23	1.90	-12	0.53	11	1.49
Basic Earnings per Share	($0.34)	($0.28)	($0.22)	($0.30)	($0.28)	($0.43)	($0.36)	($0.41)	($0.41)	($0.37)	($0.04)
Weighted Average Basic Shares Outstanding	238.34M	238.31M	238.59M	238.68M	238.89M	238.84M	239.19M	239.33M	239.67M	239.54M	239.96M
Diluted Earnings per Share	($0.34)	($0.28)	($0.22)	($0.30)	($0.28)	($0.43)	($0.36)	($0.41)	($0.41)	($0.37)	($0.04)
Weighted Average Diluted Shares Outstanding	238.34M	238.31M	238.59M	238.68M	238.89M	238.84M	239.19M	239.33M	239.67M	239.54M	239.96M
Weighted Average Basic & Diluted Shares Outstanding	239.70M	239.68M	239.68M	239.79M	240.45M	240.42M	240.39M	240.57M	241.28M	241.27M	241.25M
Cash Dividends to Common per Share	-	-	-	-	-	-	-	-	$0.01	-	$0.01

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-329	-441	-97
Net Cash From Operating Activities	-40	10	112
Net Cash From Continuing Operating Activities	-40	10	112
Net Income / (Loss) Continuing Operations	-16	-294	-370
Consolidated Net Income / (Loss)	-16	-294	-370
Depreciation Expense	239	284	285
Amortization Expense	8.90	12	104
Non-Cash Adjustments To Reconcile Net Income	-274	36	87
Changes in Operating Assets and Liabilities, net	1.64	-28	6.82
Net Cash From Investing Activities	388	-202	-187
Net Cash From Continuing Investing Activities	388	-202	-187
Purchase of Property, Plant & Equipment	-299	-235	-202
Acquisitions	-75	0.00	-21
Sale of Property, Plant & Equipment	0.82	18	34
Divestitures	108	0.00	0.00
Sale and/or Maturity of Investments	638	0.00	0.00
Other Investing Activities, net	14	15	1.70
Net Cash From Financing Activities	-676	-250	-22
Net Cash From Continuing Financing Activities	-676	-250	-22
Repayment of Debt	-666	-990	-132
Repurchase of Common Equity	-0.17	-0.39	-0.90
Payment of Dividends	-9.57	-9.60	-9.63
Issuance of Debt	0.00	750	120

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-68	-113	-306	-26	-78	-32	-39	62	-8.69	-112	157
Net Cash From Operating Activities	-5.09	-3.41	6.04	26	-14	-7.21	29	44	21	18	-3.24
Net Cash From Continuing Operating Activities	-5.09	-3.41	6.04	26	-14	-7.21	29	44	21	18	-3.24
Net Income / (Loss) Continuing Operations	-81	-65	-53	-73	-66	-103	-86	-98	-99	-87	-8.99
Consolidated Net Income / (Loss)	-81	-65	-53	-73	-66	-103	-86	-98	-99	-87	-8.99
Depreciation Expense	60	63	65	68	67	84	70	68	69	78	68
Amortization Expense	1.95	2.00	1.76	2.27	2.32	5.22	25	26	26	27	26
Non-Cash Adjustments To Reconcile Net Income	4.12	6.09	-3.42	14	1.58	24	17	32	22	17	-87
Changes in Operating Assets and Liabilities, net	9.92	-9.53	-4.44	14	-19	-18	3.16	17	2.93	-16	-1.58
Net Cash From Investing Activities	-44	-96	-57	-34	-60	-51	-59	-37	-25	-66	291
Net Cash From Continuing Investing Activities	-44	-96	-57	-34	-60	-51	-59	-37	-25	-66	291
Purchase of Property, Plant & Equipment	-72	-110	-60	-48	-60	-67	-47	-41	-47	-67	-40
Acquisitions	-	-	0.00	-	-	-	-15	-	-	-5.72	-5.80
Sale of Property, Plant & Equipment	0.03	-	3.55	-	-	15	3.34	3.98	21	6.32	318
Sale and/or Maturity of Investments	-	-	-	-	-	-	-	-	-	-	17
Other Investing Activities, net	-	14	-	-	-	0.53	-	-	1.53	-	1.31
Net Cash From Financing Activities	-19	-13	-255	-18	-3.48	26	-8.56	54	-4.63	-64	-131
Net Cash From Continuing Financing Activities	-19	-13	-255	-18	-3.48	26	-8.56	54	-4.63	-64	-131
Repayment of Debt	-16	-11	-253	-15	-0.73	-721	-6.08	-63	-1.44	-61	-269
Repurchase of Common Equity	-0.16	-0.01	-0.01	-0.03	-0.35	-0.01	-0.08	-0.04	-0.78	-0.00	-0.01
Payment of Dividends	-2.39	-2.40	-2.40	-2.40	-2.40	-2.40	-2.40	-2.40	-2.41	-2.41	-2.41
Issuance of Debt	-	-	-	-	-	750	-	-	-	-	140

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	6,002	5,446	5,137
Total Current Assets	667	253	149
Cash & Equivalents	658	246	145
Accounts Receivable	8.72	6.08	4.06
Plant, Property, & Equipment, net	4,864	4,798	4,340
Plant, Property & Equipment, gross	6,693	6,818	6,423
Accumulated Depreciation	1,828	2,021	2,083
Total Noncurrent Assets	471	395	648
Long-Term Investments	161	130	151
Intangible Assets	45	34	26
Other Noncurrent Operating Assets	264	232	470
Total Liabilities & Shareholders' Equity	6,002	5,446	5,137
Total Liabilities	3,363	3,109	3,178
Total Current Liabilities	0.00	0.03	0.00
Total Noncurrent Liabilities	3,363	3,089	3,178
Long-Term Debt	3,018	2,804	2,784
Other Noncurrent Operating Liabilities	346	285	388
Other Noncurrent Nonoperating Liabilities	0.00	-	6.02
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,639	2,337	1,959
Total Preferred & Common Equity	2,639	2,337	1,959
Total Common Equity	2,639	2,337	1,959
Common Stock	4,619	4,621	4,623
Retained Earnings	2,072	1,778	1,408
Accumulated Other Comprehensive Income / (Loss)	-	0.00	-0.02
Other Equity Adjustments	-4,053	-4,062	-4,072

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	6,072	5,667	5,585	5,530	5,348	5,333	5,285	4,996
Total Current Assets	801	383	357	279	208	266	257	303
Cash & Equivalents	691	380	338	278	207	266	257	303
Plant, Property, & Equipment, net	4,812	4,845	4,804	4,801	4,709	4,655	4,562	4,255
Plant, Property & Equipment, gross	6,597	6,724	6,712	6,767	6,771	6,762	6,673	6,367
Accumulated Depreciation	1,785	1,879	1,908	1,966	2,062	2,107	2,111	2,112
Total Noncurrent Assets	460	439	425	450	431	413	467	438
Long-Term Investments	159	153	155	154	146	134	134	142
Intangible Assets	48	42	39	37	32	30	28	24
Other Noncurrent Operating Assets	252	244	230	260	253	250	305	272
Total Liabilities & Shareholders' Equity	6,072	5,667	5,585	5,530	5,348	5,333	5,285	4,996
Total Liabilities	3,366	3,083	3,076	3,089	3,099	3,184	3,237	3,048
Total Current Liabilities	700	450	450	450	0.22	0.00	0.00	0.00
Total Noncurrent Liabilities	2,666	2,633	2,626	2,638	3,087	3,184	3,237	3,048
Long-Term Debt	2,357	2,348	2,335	2,335	2,826	2,920	2,945	2,800
Other Noncurrent Operating Liabilities	308	284	291	303	261	264	289	242
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	0.58	2.62	5.57
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,706	2,584	2,509	2,442	2,249	2,149	2,048	1,948
Total Preferred & Common Equity	2,706	2,584	2,509	2,442	2,249	2,149	2,048	1,948
Total Common Equity	2,706	2,584	2,509	2,442	2,249	2,149	2,048	1,948
Common Stock	4,619	4,620	4,620	4,621	4,621	4,622	4,622	4,623
Retained Earnings	2,137	2,019	1,947	1,881	1,692	1,594	1,495	1,399
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-0.00	-0.03	0.01	0.00
Other Equity Adjustments	-4,050	-4,055	-4,057	-4,060	-4,065	-4,067	-4,069	-4,074

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-7.20%	9.87%	6.04%
EBITDA Growth	-71.86%	-57.04%	25.91%
EBIT Growth	-56.11%	-150.44%	-41.82%
NOPAT Growth	-177.62%	-10.09%	-21.83%
Net Income Growth	-108.77%	-1,761.11%	-26.12%
EPS Growth	-109.59%	-1,657.14%	-26.02%
Operating Cash Flow Growth	36.27%	125.98%	970.52%
Free Cash Flow Firm Growth	-81.19%	-111.21%	1,353.20%
Invested Capital Growth	-4.70%	-1.09%	-6.92%
Revenue Q/Q Growth	0.01%	1.78%	1.22%
EBITDA Q/Q Growth	244.82%	15.78%	2.96%
EBIT Q/Q Growth	265.16%	2.73%	-6.20%
NOPAT Q/Q Growth	46.24%	-16.22%	-7.26%
Net Income Q/Q Growth	-103.79%	-14.53%	3.92%
EPS Q/Q Growth	-104.02%	-13.89%	3.73%
Operating Cash Flow Q/Q Growth	53.66%	-26.63%	29.26%
Free Cash Flow Firm Q/Q Growth	-83.18%	62.67%	128.05%
Invested Capital Q/Q Growth	1.47%	-0.21%	-3.31%
Profitability Metrics	-	-	-
Gross Margin	200.00%	100.00%	100.00%
EBITDA Margin	35.10%	13.73%	16.30%
Operating Margin	10.46%	-7.32%	-8.41%
EBIT Margin	33.53%	-7.24%	-9.68%
Profit (Net Income) Margin	-1.23%	-20.82%	-24.76%
Tax Burden Percent	74.69%	107.67%	99.70%
Interest Burden Percent	-19.70%	267.10%	256.53%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.33%	-1.50%	-1.91%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-11.03%	-13.33%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-10.30%	-15.33%
Return on Equity (ROE)	0.00%	-11.80%	-17.24%
Cash Return on Invested Capital (CROIC)	3.49%	-0.40%	5.26%
Operating Return on Assets (OROA)	3.21%	-1.78%	-2.74%
Return on Assets (ROA)	-0.25%	-5.13%	-7.00%
Return on Common Equity (ROCE)	0.00%	-11.80%	-17.24%
Return on Equity Simple (ROE_SIMPLE)	-0.60%	-12.56%	-18.90%
Net Operating Profit after Tax (NOPAT)	-66	-72	-88
NOPAT Margin	7.32%	-5.13%	-5.89%
Net Nonoperating Expense Percent (NNEP)	-2.16%	9.53%	11.42%
Return On Investment Capital (ROIC_SIMPLE)	-1.16%	-1.41%	-1.86%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	88.46%	85.11%	84.46%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	214.62%	107.32%	108.41%
Earnings before Interest and Taxes (EBIT)	202	-102	-145
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	451	194	244
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.06	0.38	0.28
Price to Tangible Book Value (P/TBV)	0.06	0.38	0.29
Price to Revenue (P/Rev)	0.23	0.63	0.37
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	13.03%	1.09%	1.75%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.48	0.69	0.68
Enterprise Value to Revenue (EV/Rev)	1.83	2.35	2.03
Enterprise Value to EBITDA (EV/EBITDA)	10.41	17.10	12.48
Enterprise Value to EBIT (EV/EBIT)	11.59	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	315.72	27.09
Enterprise Value to Free Cash Flow (EV/FCFF)	27.16	0.00	12.53
Leverage & Solvency	-	-	-
Debt to Equity	0.00	1.20	1.42
Long-Term Debt to Equity	0.00	1.20	1.42
Financial Leverage	0.00	0.93	1.15
Leverage Ratio	0.00	2.30	2.46
Compound Leverage Factor	0.00	6.15	6.32
Debt to Total Capital	53.35%	54.54%	58.70%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	53.35%	54.54%	58.70%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.65%	45.46%	41.30%
Debt to EBITDA	6.70	14.49	11.42
Net Debt to EBITDA	9.76	12.54	10.21
Long-Term Debt to EBITDA	13.40	14.49	11.42
Debt to NOPAT	-26.85	-38.78	-31.61
Net Debt to NOPAT	-19.66	-33.57	-28.25
Long-Term Debt to NOPAT	-45.95	-38.78	-31.61
Altman Z-Score	0.00	0.88	0.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	0.00	7,907.56	0.00
Quick Ratio	0.00	7,875.63	0.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	173	-19	243
Operating Cash Flow to CapEx	-13.52%	4.84%	66.98%
Free Cash Flow to Firm to Interest Expense	2.36	-0.10	1.03
Operating Cash Flow to Interest Expense	-0.17	0.05	0.48
Operating Cash Flow Less CapEx to Interest Expense	-1.42	-1.06	-0.23
Efficiency Ratios	-	-	-
Asset Turnover	0.20	0.25	0.28
Accounts Receivable Turnover	0.00	190.62	295.01
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.26	0.29	0.33
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	1.91	1.24
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	1.91	1.24
Capital & Investment Metrics	-	-	-
Invested Capital	4,837	4,784	4,453
Invested Capital Turnover	0.26	0.29	0.32
Increase / (Decrease) in Invested Capital	-238	-53	-331
Enterprise Value (EV)	2,346	3,310	3,041
Market Capitalization	147	883	552
Book Value per Share	$11.01	$9.72	$8.12
Tangible Book Value per Share	$10.82	$9.58	$8.01
Total Capital	5,656	5,141	4,743
Total Debt	3,018	2,804	2,784
Total Long-Term Debt	3,018	2,804	2,784
Net Debt	2,198	2,427	2,488
Capital Expenditures (CapEx)	299	217	168
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.72	6.05	4.06
Debt-free Net Working Capital (DFNWC)	667	253	149
Net Working Capital (NWC)	667	253	149
Net Nonoperating Expense (NNE)	-50	221	282
Net Nonoperating Obligations (NNO)	2,198	2,447	2,494
Total Depreciation and Amortization (D&A)	248	296	389
Debt-free, Cash-free Net Working Capital to Revenue	1.36%	0.43%	0.27%
Debt-free Net Working Capital to Revenue	105.57%	17.94%	9.94%
Net Working Capital to Revenue	103.90%	17.94%	9.94%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.07)	($1.23)	($1.55)
Adjusted Weighted Average Basic Shares Outstanding	238.31M	238.84M	239.54M
Adjusted Diluted Earnings per Share	($0.07)	($1.23)	($1.55)
Adjusted Weighted Average Diluted Shares Outstanding	238.31M	238.84M	239.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	239.68M	240.42M	241.27M
Normalized Net Operating Profit after Tax (NOPAT)	-64	-52	-37
Normalized NOPAT Margin	-9.95%	-3.68%	-2.46%
Pre Tax Income Margin	-3.29%	-19.33%	-24.83%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.85	-0.53	-0.61
NOPAT to Interest Expense	0.39	-0.37	-0.37
EBIT Less CapEx to Interest Expense	-0.40	-1.64	-1.33
NOPAT Less CapEx to Interest Expense	-0.85	-1.49	-1.09
Payout Ratios	-	-	-
Dividend Payout Ratio	-60.66%	-3.27%	-2.60%
Augmented Payout Ratio	-61.74%	-3.40%	-2.84%

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.30%	0.05%	11.36%	10.60%	10.41%	7.32%	7.15%	7.27%	4.80%	5.00%	4.34%
EBITDA Growth	-48.28%	27.18%	-85.64%	-7.83%	100.40%	88.34%	22.15%	73.04%	8.95%	12.46%	170.57%
EBIT Growth	-59.45%	24.32%	-105.24%	-66.80%	45.06%	8.08%	-110.41%	12.57%	-101.62%	-25.90%	327.94%
NOPAT Growth	-253.98%	72.83%	49.78%	-72.79%	36.67%	-79.29%	-59.83%	52.58%	-102.15%	-26.12%	-33.65%
Net Income Growth	7.40%	-117.81%	-121.90%	33.65%	19.28%	-57.01%	-63.81%	-34.85%	-50.03%	14.74%	89.58%
EPS Growth	10.53%	-118.30%	-121.78%	34.78%	17.65%	-53.57%	-63.64%	-36.67%	-46.43%	13.95%	88.89%
Operating Cash Flow Growth	87.35%	93.21%	183.18%	204.43%	-175.55%	-111.72%	373.39%	72.47%	250.62%	352.39%	-111.34%
Free Cash Flow Firm Growth	609.33%	-75.00%	-110.65%	-97.34%	-100.38%	-86.65%	169.11%	224.87%	3,773.50%	902.85%	319.15%
Invested Capital Growth	-19.30%	-4.70%	2.66%	-1.12%	-0.21%	-1.09%	-2.35%	-2.33%	-3.93%	-6.92%	-8.94%
Revenue Q/Q Growth	3.16%	4.32%	2.71%	0.05%	2.98%	1.41%	2.56%	0.17%	0.61%	1.60%	1.91%
EBITDA Q/Q Growth	-40.59%	1,467.78%	70.94%	-26.28%	29.18%	15.69%	10.87%	4.43%	-18.66%	19.42%	166.86%
EBIT Q/Q Growth	-92.39%	919.07%	56.30%	-112.98%	36.63%	-55.84%	-0.04%	11.51%	-46.14%	2.69%	281.13%
NOPAT Q/Q Growth	-72.91%	1,063.84%	7.90%	-97.29%	36.63%	-55.71%	17.90%	41.46%	-170.13%	2.86%	13.00%
Net Income Q/Q Growth	25.50%	19.84%	19.39%	-37.82%	9.36%	-55.92%	15.90%	-13.45%	-0.85%	11.39%	89.72%
EPS Q/Q Growth	26.09%	17.65%	21.43%	-36.36%	6.67%	-53.57%	16.28%	-13.89%	0.00%	9.76%	89.19%
Operating Cash Flow Q/Q Growth	79.29%	33.13%	277.44%	325.04%	-154.64%	48.62%	496.75%	54.86%	-52.28%	-13.91%	-117.82%
Free Cash Flow Firm Q/Q Growth	-3.21%	-79.96%	-160.86%	122.52%	-113.99%	796.09%	215.14%	5.87%	58.17%	90.03%	31.72%
Invested Capital Q/Q Growth	-0.65%	1.47%	0.19%	-1.33%	0.25%	-0.21%	-1.07%	-1.31%	-1.39%	-3.31%	-3.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	200.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	7.51%	8.87%	29.51%	10.87%	13.64%	15.56%	16.82%	17.54%	14.18%	16.66%	43.64%
Operating Margin	-10.24%	-5.40%	-9.32%	-9.54%	-5.87%	-9.01%	-7.22%	-4.22%	-11.32%	-10.83%	-9.24%
EBIT Margin	-11.80%	-10.53%	-8.96%	-9.54%	-5.87%	-9.02%	-8.80%	-7.78%	-11.29%	-10.82%	19.23%
Profit (Net Income) Margin	-25.24%	-19.39%	-15.22%	-20.96%	-18.45%	-28.37%	-23.26%	-26.35%	-26.41%	-23.04%	-2.32%
Tax Burden Percent	97.47%	0.00%	202.37%	96.40%	100.51%	128.37%	98.06%	114.61%	99.62%	88.36%	86.20%
Interest Burden Percent	219.47%	177.05%	335.58%	227.92%	312.69%	244.96%	269.59%	295.69%	234.76%	240.99%	-14.01%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.71%	-0.98%	-0.93%	-1.88%	-1.19%	-1.85%	-1.51%	-0.91%	-2.49%	-2.45%	-2.16%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.78%	-3.26%	-2.94%	-4.17%	-3.48%	-5.28%	-4.36%	-4.54%	-5.31%	-4.83%	-1.50%
Return on Net Nonoperating Assets (RNNOA)	-4.17%	-2.84%	-2.19%	-3.40%	-3.01%	-4.93%	-4.28%	-4.67%	-5.80%	-5.55%	-1.73%
Return on Equity (ROE)	-5.88%	-3.81%	-3.12%	-5.27%	-4.20%	-6.78%	-5.80%	-5.58%	-8.29%	-8.01%	-3.90%
Cash Return on Invested Capital (CROIC)	19.10%	3.49%	-3.07%	-0.35%	-1.08%	-0.40%	0.72%	0.94%	2.26%	5.26%	7.27%
Operating Return on Assets (OROA)	-2.30%	-2.14%	-0.95%	-2.20%	-1.40%	-2.22%	-2.29%	-2.08%	-3.09%	-3.06%	5.62%
Return on Assets (ROA)	-4.93%	-3.94%	-3.23%	-4.83%	-4.41%	-6.99%	-6.06%	-7.05%	-7.22%	-6.51%	-0.68%
Return on Common Equity (ROCE)	-5.75%	-3.81%	-3.12%	-5.27%	-4.20%	-6.78%	-5.80%	-5.58%	-8.29%	-8.01%	-3.90%
Return on Equity Simple (ROE_SIMPLE)	15.38%	0.00%	-11.95%	-10.84%	-10.50%	0.00%	-14.55%	-16.40%	-18.81%	0.00%	-15.04%
Net Operating Profit after Tax (NOPAT)	-23	-13	-12	-23	-15	-23	-19	-11	-30	-29	-25
NOPAT Margin	-7.16%	-3.78%	-3.39%	-6.68%	-4.11%	-6.31%	-5.05%	-2.95%	-7.93%	-7.58%	-6.47%
Net Nonoperating Expense Percent (NNEP)	2.07%	2.28%	2.01%	2.29%	2.30%	3.43%	2.85%	3.63%	2.81%	2.37%	-0.66%
Return On Investment Capital (ROIC_SIMPLE)	-0.40%	-0.23%	-0.22%	-0.44%	-0.28%	-0.44%	-0.37%	-0.22%	-0.59%	-0.61%	-0.53%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	91.44%	86.36%	168.74%	84.78%	85.66%	85.59%	85.00%	83.56%	86.62%	82.70%	83.58%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	110.24%	105.40%	209.68%	109.54%	105.87%	109.01%	107.22%	104.22%	111.32%	110.83%	109.24%
Earnings before Interest and Taxes (EBIT)	-38	-35	-16	-33	-21	-33	-33	-29	-42	-41	74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	24	30	51	38	49	56	62	65	53	63	169
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.08	0.06	0.24	0.21	0.19	0.38	0.26	0.34	0.49	0.28	0.30
Price to Tangible Book Value (P/TBV)	0.08	0.06	0.25	0.21	0.19	0.38	0.26	0.34	0.50	0.29	0.30
Price to Revenue (P/Rev)	0.17	0.23	0.24	0.39	0.33	0.63	0.41	0.50	0.68	0.37	0.38
Price to Earnings (P/E)	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	4.29%	13.03%	6.15%	1.83%	2.11%	1.09%	1.65%	1.33%	0.96%	1.75%	1.67%
Earnings Yield	186.39%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.48	0.48	1.06	0.58	0.59	0.69	0.65	0.70	0.77	0.68	0.68
Enterprise Value to Revenue (EV/Rev)	1.81	1.83	1.95	2.07	2.03	2.35	2.13	2.22	2.41	2.03	1.94
Enterprise Value to EBITDA (EV/EBITDA)	17.76	10.41	17.63	19.58	16.79	17.10	14.91	13.97	15.02	12.48	8.37
Enterprise Value to EBIT (EV/EBIT)	0.00	11.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	120.42	196.43	315.72	92.43	62.84	40.95	27.09	36.48
Enterprise Value to Free Cash Flow (EV/FCFF)	2.26	13.58	0.00	0.00	0.00	0.00	88.95	73.27	33.40	12.53	8.93
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.13	1.14	2.17	1.11	1.14	1.20	1.26	1.36	1.44	1.42	1.44
Long-Term Debt to Equity	0.87	1.14	1.82	0.93	0.96	1.20	1.26	1.36	1.44	1.42	1.44
Financial Leverage	1.10	0.87	1.49	0.82	0.86	0.93	0.98	1.03	1.09	1.15	1.15
Leverage Ratio	2.57	2.38	4.54	2.21	2.25	2.30	2.28	2.34	2.41	2.46	2.46
Compound Leverage Factor	5.64	4.22	15.23	5.05	7.05	5.64	6.14	6.93	5.65	5.94	-0.35
Debt to Total Capital	53.06%	53.35%	103.99%	52.60%	53.29%	54.54%	55.68%	57.60%	58.98%	58.70%	58.98%
Short-Term Debt to Total Capital	12.14%	0.00%	16.72%	8.50%	8.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	40.92%	53.35%	43.63%	44.10%	44.68%	54.54%	55.68%	57.60%	58.98%	58.70%	58.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.94%	46.65%	48.01%	47.40%	46.71%	45.46%	44.32%	42.40%	41.02%	41.30%	41.03%
Debt to EBITDA	23.41	6.70	19.17	19.50	16.66	14.49	13.79	12.57	12.44	11.42	8.00
Net Debt to EBITDA	16.06	4.88	15.49	15.91	14.07	12.54	12.06	10.85	10.79	10.21	6.73
Long-Term Debt to EBITDA	18.05	6.70	16.08	16.35	13.97	14.49	13.79	12.57	12.44	11.42	8.00
Debt to NOPAT	-25.04	-45.95	-45.91	-39.39	-44.76	-38.78	-35.63	-43.48	-35.86	-31.61	-29.67
Net Debt to NOPAT	-17.18	-33.47	-37.11	-32.14	-37.81	-33.57	-31.16	-37.53	-31.11	-28.25	-24.96
Long-Term Debt to NOPAT	-19.31	-45.95	-38.53	-33.02	-37.53	-38.78	-35.63	-43.48	-35.86	-31.61	-29.67
Altman Z-Score	0.74	0.84	0.77	0.79	0.77	0.92	0.85	0.87	0.89	0.79	0.93
Noncontrolling Interest Sharing Ratio	2.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.14	0.00	0.85	0.79	0.62	7,907.56	954.88	0.00	0.00	0.00	0.00
Quick Ratio	0.99	0.00	1.69	0.75	0.62	7,875.63	950.11	0.00	0.00	0.00	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,126	226	-137	31	-4.33	30	95	100	159	302	398
Operating Cash Flow to CapEx	-7.03%	-3.09%	10.65%	53.90%	-23.20%	-13.92%	65.93%	119.64%	79.10%	30.12%	0.00%
Free Cash Flow to Firm to Interest Expense	23.99	4.57	-2.81	0.65	-0.09	0.60	1.65	1.71	2.67	5.07	4.58
Operating Cash Flow to Interest Expense	-0.11	-0.07	0.12	0.54	-0.29	-0.14	0.50	0.75	0.36	0.31	-0.04
Operating Cash Flow Less CapEx to Interest Expense	-1.65	-2.30	-1.04	-0.46	-1.56	-1.17	-0.26	0.12	-0.09	-0.71	3.17
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.20	0.20	0.21	0.23	0.24	0.25	0.26	0.27	0.27	0.28	0.29
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	190.62	0.00	0.00	0.00	295.01	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.24	0.26	0.28	0.28	0.29	0.29	0.30	0.31	0.32	0.33	0.34
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	1.91	0.00	0.00	0.00	1.24	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	1.91	0.00	0.00	0.00	1.24	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,804	4,837	4,846	4,782	4,794	4,784	4,733	4,671	4,606	4,453	4,310
Invested Capital Turnover	0.24	0.26	0.28	0.28	0.29	0.29	0.30	0.31	0.31	0.32	0.33
Increase / (Decrease) in Invested Capital	-1,149	-238	126	-54	-10	-53	-114	-111	-189	-331	-423
Enterprise Value (EV)	2,321	4,700	2,574	2,797	2,806	3,310	3,054	3,246	3,555	3,041	2,933
Market Capitalization	223	147	630	525	454	883	583	725	1,000	552	576
Book Value per Share	$11.32	$11.01	$10.78	$10.47	$10.18	$9.72	$9.40	$8.94	$8.51	$8.12	$8.07
Tangible Book Value per Share	$11.11	$10.82	$10.60	$10.31	$10.03	$9.58	$9.27	$8.82	$8.40	$8.01	$7.97
Total Capital	5,765	5,656	5,382	5,294	5,227	5,141	5,074	5,069	4,994	4,743	4,748
Total Debt	3,059	3,018	2,798	2,785	2,785	2,804	2,826	2,920	2,945	2,784	2,800
Total Long-Term Debt	2,359	3,018	2,348	2,335	2,335	2,804	2,826	2,920	2,945	2,784	2,800
Net Debt	2,098	2,198	2,262	2,272	2,352	2,427	2,471	2,521	2,554	2,488	2,356
Capital Expenditures (CapEx)	72	110	57	48	60	52	43	37	27	60	-279
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	8.72	0.00	-0.31	-0.43	6.05	-0.22	0.00	0.00	4.06	0.00
Debt-free Net Working Capital (DFNWC)	801	667	383	357	279	253	208	266	257	149	303
Net Working Capital (NWC)	101	667	-67	-93	-171	253	208	266	257	149	303
Net Nonoperating Expense (NNE)	58	53	41	49	51	80	68	87	69	59	-16
Net Nonoperating Obligations (NNO)	2,098	2,198	2,262	2,273	2,353	2,447	2,484	2,521	2,557	2,494	2,362
Total Depreciation and Amortization (D&A)	62	65	67	71	70	89	95	94	95	104	94
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.68%	0.00%	-0.02%	-0.03%	0.43%	-0.02%	0.00%	0.00%	0.27%	0.00%
Debt-free Net Working Capital to Revenue	62.40%	51.95%	29.02%	26.39%	20.11%	17.94%	14.49%	18.19%	17.36%	9.94%	20.02%
Net Working Capital to Revenue	7.85%	103.90%	-5.11%	-6.89%	-12.36%	17.94%	14.49%	18.19%	17.36%	9.94%	20.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.34)	($0.28)	($0.22)	($0.30)	($0.28)	($0.43)	($0.36)	($0.41)	($0.41)	($0.37)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	238.34M	238.31M	238.59M	238.68M	238.89M	238.84M	239.19M	239.33M	239.67M	239.54M	239.96M
Adjusted Diluted Earnings per Share	($0.34)	($0.28)	($0.22)	($0.30)	($0.28)	($0.43)	($0.36)	($0.41)	($0.41)	($0.37)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	238.34M	238.31M	238.59M	238.68M	238.89M	238.84M	239.19M	239.33M	239.67M	239.54M	239.96M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	239.70M	239.68M	239.68M	239.79M	240.45M	240.42M	240.39M	240.57M	241.28M	241.27M	241.25M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-12	-7.51	-11	-11	-22	-10	-5.10	-13	-8.27	-3.35
Normalized NOPAT Margin	-7.10%	-3.62%	-2.17%	-3.17%	-3.16%	-6.11%	-2.74%	-1.37%	-3.55%	-2.18%	-0.87%
Pre Tax Income Margin	-25.89%	-18.65%	-30.08%	-21.74%	-18.36%	-22.10%	-23.73%	-22.99%	-26.51%	-26.07%	-2.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.81	-0.72	-0.63	-0.70	-0.44	-0.65	-0.57	-0.49	-0.71	-0.69	0.86
NOPAT to Interest Expense	-0.49	-0.26	-0.46	-0.49	-0.31	-0.45	-0.33	-0.19	-0.50	-0.48	-0.29
EBIT Less CapEx to Interest Expense	-2.36	-2.95	-1.80	-1.70	-1.70	-1.68	-1.32	-1.12	-1.16	-1.70	4.06
NOPAT Less CapEx to Interest Expense	-2.04	-2.49	-1.62	-1.49	-1.57	-1.48	-1.08	-0.81	-0.95	-1.50	2.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	3.62%	-60.66%	-3.10%	-3.52%	-3.74%	-3.27%	-2.93%	-2.73%	-2.50%	-2.60%	-3.29%
Augmented Payout Ratio	3.66%	-61.74%	-3.16%	-3.60%	-3.89%	-3.40%	-3.08%	-2.86%	-2.73%	-2.84%	-3.57%

Frequently Asked Questions About Diversified Healthcare Trust's Financials

When does Diversified Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Diversified Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Diversified Healthcare Trust's net income changed over the last 2 years?

Diversified Healthcare Trust's net income appears to be on an upward trend, with a most recent value of -$370.26 million in 2024, rising from -$15.77 million in 2022. The previous period was -$293.57 million in 2023. See Diversified Healthcare Trust's forecast for analyst expectations on what’s next for the company.

What is Diversified Healthcare Trust's operating income?

Diversified Healthcare Trust's total operating income in 2024 was -$125.83 million, based on the following breakdown:

Total Gross Profit: $1.50 billion
Total Operating Expenses: $1.62 billion

How has Diversified Healthcare Trust revenue changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's total revenue changed from $1.28 billion in 2022 to $1.50 billion in 2024, a change of 16.5%.

How much debt does Diversified Healthcare Trust have?

Diversified Healthcare Trust's total liabilities were at $3.18 billion at the end of 2024, a 2.2% increase from 2023, and a 5.5% decrease since 2022.

How much cash does Diversified Healthcare Trust have?

In the past 2 years, Diversified Healthcare Trust's cash and equivalents has ranged from $144.58 million in 2024 to $658.07 million in 2022, and is currently $144.58 million as of their latest financial filing in 2024.

How has Diversified Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's book value per share changed from 11.01 in 2022 to 8.12 in 2024, a change of -26.2%.

Related Companies

This page (NASDAQ:DHC) was last updated on 6/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Diversified Healthcare Trust (DHC) Financials

Frequently Asked Questions About Diversified Healthcare Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Diversified Healthcare Trust (DHC) Financials

Annual Income Statements for Diversified Healthcare Trust

Quarterly Income Statements for Diversified Healthcare Trust

Annual Cash Flow Statements for Diversified Healthcare Trust

Quarterly Cash Flow Statements for Diversified Healthcare Trust

Annual Balance Sheets for Diversified Healthcare Trust

Quarterly Balance Sheets for Diversified Healthcare Trust

Annual Metrics And Ratios for Diversified Healthcare Trust

Quarterly Metrics And Ratios for Diversified Healthcare Trust

Frequently Asked Questions About Diversified Healthcare Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools